Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $34.0600 (5.84%) ($31.0100 - $35.0000) on Thu. Oct. 25, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.33% (three month average) | RSI | 33 | Latest Price | $34.0600(5.84%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -1% a day on average for past five trading days. | Weekly Trend | ATRA declines -4.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(59%) ARKG(51%) IBB(51%) IWO(50%) ARKK(49%) | Factors Impacting ATRA price | ATRA will decline at least -1.665% in a week (0% probabilities). VXX(-14%) VIXM(-14%) TLT(-14%) UUP(-12%) UNG(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.665% (StdDev 3.33%) | Hourly BBV | 0 () | Intraday Trend | 4.6% | | | |
|
1 - 5 Day Possible Target | $21.24(-37.64%) | Resistance Level | $37.06 | 5 Day Moving Average | $33.98(0.24%) | 10 Day Moving Average | $35.33(-3.59%) | 20 Day Moving Average | $37.06(-8.09%) | To recent high | -21.7% | To recent low | 5.8% | Market Cap | $2.531b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |